Clinical Trial Update: A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating aripiprazole for the management of schizophrenia in general psychiatric practice has completed, with results summarizing efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED